Oxidative Balance, Inflammation Linked to RA Mortality

Higher oxidative balance was associated with lower mortality, while greater systemic inflammation was linked to increased risk in a US cohort of patients with rheumatoid arthritis.

By
Andrea Surnit
April 20, 2026
3 min

Conexiant

Overview

A retrospective cohort study found that higher oxidative balance is linked to lower all-cause mortality specifically in rheumatoid arthritis (RA) patients, while greater systemic inflammation correlates with increased mortality. The study analyzed data from 812 RA patients within a cohort of 24,552 adults, revealing significant associations between oxidative balance scores and mortality risk.

Background

Rheumatoid arthritis (RA) is a prevalent autoimmune disease that significantly impacts patient quality of life and increases mortality risk. Understanding the relationship between oxidative balance, inflammation, and mortality is crucial for improving patient outcomes and developing targeted interventions. This study provides insights into potential biomarkers for risk stratification in RA patients.

Data Highlights

Measure	Association with Mortality
1-point increase in oxidative balance score	4% lower mortality risk
Higher oxidative balance scores	37% lower mortality risk
1-unit increase in systemic inflammation response index	14% higher mortality risk
High inflammation and low oxidative balance	Poorest survival
Systemic inflammation response index > 1.073	Increased mortality risk
Oxidative balance score ≤ 18.482	Elevated risk

Key Findings

Higher oxidative balance is associated with lower all-cause mortality in RA patients.
Each 1-point increase in oxidative balance score correlates with a 4% reduction in mortality risk.
Greater systemic inflammation is linked to a 14% increase in mortality risk.
Patients with high inflammation and low oxidative balance exhibit the poorest survival outcomes.
Oxidative balance and inflammation were measured at a single time point, limiting longitudinal assessment.
Potential risk thresholds for mortality were identified based on inflammation and oxidative balance scores.
Limitations include the observational design, which does not establish causality.

Clinical Implications

Clinicians should consider assessing oxidative balance and systemic inflammation in RA patients to better stratify risk and tailor management strategies. These findings highlight the importance of lifestyle factors that may improve oxidative balance and potentially reduce mortality risk, but further research is needed to establish causality.

Conclusion

The study underscores the critical role of oxidative balance and inflammation in determining mortality risk among patients with rheumatoid arthritis, suggesting avenues for future research and clinical practice improvements. The observational nature of the study limits causal inferences.